Erlotinib or Chemotherapy in Second-Line or Later Treatment of Tumor EGFR Wild-Type Pulmonary Adenocarcinoma Patients

Background: The intent of this study was to explore the treatment efficacy of erlotinib, pemetrexed or docetaxel in individual patients with tumor EGFR wild-type pulmonary adenocarcinoma who failed previous chemotherapy. Methods: We retrospectively reviewed the clinical data of our EGFR wild-type pu...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yuh-Min Chen, Yung-Hung Luo, Chieh-Hung Wu, Yu-Chin Lee, Reury-Perng Perng, Jacqueline Whang-Peng
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wolters Kluwer Medknow Publications 2015-03-01
Cyfres:	Journal of Cancer Research and Practice
Pynciau:	adenocarcinoma docetaxel erlotinib non-small-cell lung cancer pemetrexed
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2311300616300544
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!